Jushi Holdings (JUSHF) Cost of Revenue (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Cost of Revenue came in at $36.6 million in Q1 2026, down 3.98% year-on-year from $38.1 million in Q1 2025, and down 7.98% on a QoQ basis from $39.7 million in Q4 2025.

Jushi Holdings (JUSHF) Cost of Revenue (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Cost of Revenue data on file, last reported at $36.6 million in Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 3.98% year-over-year to $36.6 million in Q1 2026; TTM through Mar 2026 was $147.4 million, a 2.26% increase from a year earlier, with the FY2025 full-year figure at $148.9 million, up 6.97% from the prior year.
  • Cost of Revenue for Q1 2026 stood at $36.6 million, down from $39.7 million in the prior quarter.
  • Over the last five years, Cost of Revenue for JUSHF reached as high as $54.9 million in Q4 2022 and fell as low as $32.0 million in Q2 2024.
  • Historically, Cost of Revenue has averaged $39.2 million across 5 years, with a median of $38.1 million in 2025.
  • Across the five-year window, Cost of Revenue jumped 76.41% in 2022 and fell 26.09% in 2023, its largest moves.
  • Year by year, Cost of Revenue stood at $54.9 million in 2022, then retreated by 26.09% to $40.6 million in 2023, then dropped by 0.24% to $40.5 million in 2024, then declined by 1.8% to $39.7 million in 2025, then slipped by 7.98% to $36.6 million in 2026.
  • Per Business Quant data, the three most recent Cost of Revenue figures were $36.6 million in Q1 2026, $39.7 million in Q4 2025, and $35.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 36.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.56 Mn
Mar 31, 2026 36.56 Mn
Dec 31, 2025 39.72 Mn
Dec 31, 2025 39.72 Mn
Sep 30, 2025 35.02 Mn
Sep 30, 2025 35.02 Mn
Jun 30, 2025 36.12 Mn
Jun 30, 2025 36.12 Mn
Mar 31, 2025 38.07 Mn
Mar 31, 2025 38.07 Mn
Dec 31, 2024 40.45 Mn
Dec 31, 2024 40.45 Mn
Sep 30, 2024 33.61 Mn
Sep 30, 2024 33.61 Mn
Jun 30, 2024 32.03 Mn
Jun 30, 2024 32.03 Mn
Mar 31, 2024 33.13 Mn
Mar 31, 2024 33.13 Mn
Dec 31, 2023 40.55 Mn
Dec 31, 2023 40.55 Mn